High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals

被引：6

作者：

Farmakis, Dimitrios ^{[1
]}

Richter, Dimitrios ^{[2
]}

Chronopoulou, Genovefa ^{[3
]}

Goumas, George ^{[2
]}

Kountouras, Dimitrios ^{[4
]}

Mastorakou, Anna ^{[5
]}

Papingiotis, Georgios ^{[6
]}

Hahalis, George ^{[7
]}

Tsiou, Konstantinos ^{[8
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Cardiol, Med Sch, Athens, Greece

[2] Euroclin Hosp, Athens, Greece

[3] Athens Med Ctr, Cent Biopathol Lab, Athens, Greece

[4] Bioiatriki Healthcare Grp, Ctr Prevent Med & Longev, Athens, Greece

[5] Bioormoniki, Patras, Greece

[6] Evangelismos Gen Hosp, Dept Cardiol, Athens, Greece

[7] Univ Patras, Med Sch, Patras, Greece

[8] Natl & Kapodistrian Univ, Hippokrat Gen Hosp, Dept Cardiol 1, Med Sch, Athens, Greece

来源：

HELLENIC JOURNAL OF CARDIOLOGY | 2024年 / 75卷

关键词：

cardiovascular risk; risk stratification; general population; troponin; high-sensitivity cardiac troponin I; COVID-19; MORTALITY; EVENTS; ASSAYS; POPULATION; PREVENTION; DISEASE; IMPACT;

D O I：

10.1016/j.hjc.2023.09.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Troponin I and T as cardiac-specific biomarkers are highly useful tools not only in the diagnosis of acute coronary syndromes but also as independent predictors of several other clinical conditions. High-sensitivity cardiac troponin (hs-cTn) assays allow the detection of considerably low concentrations of cardiac troponin in apparently healthy and asymptomatic individuals, being a candidate tool for cardiovascular risk stratification in the general population. A group of Greek experts summarized the bulk of evidence regarding the use of hs-cTnI as a predictor of cardiovascular events and mortality in apparently healthy individuals and its additive value on top of existing risk stratification methods. This document could serve as a guide for the incorporation of hs-cTnI as an additional risk stratification tool in cardiovascular prevention strategies in apparently healthy individuals. (Hellenic Journal of Cardiology 2024;75:74-81) (c) 2024 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：74 / 81

页数：8

共 38 条

[1] Comments on the European guidelines on cardiovascular disease prevention [J].

Aessopos, A ;

Farmakis, D .

EUROPEAN HEART JOURNAL, 2004, 25 (07) :619-620

[2]

[Anonymous], 2022, Cardiovascular diseases statistics

[3]

[Anonymous], 2022, Infographic-causes-death-2019-ELSTAT

[4] Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care [J].

Apple, Fred S. ;

Sandoval, Yader ;

Jaffe, Allan S. ;

Ordonez-Llanos, Jordi .

CLINICAL CHEMISTRY, 2017, 63 (01) :73-81

[5] Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population [J].

Apple, Fred S. ;

Ler, Ranka ;

Murakami, MaryAnn M. .

CLINICAL CHEMISTRY, 2012, 58 (11) :1574-1581

[6] Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium [J].

Blankenberg, Stefan ;

Salomaa, Veikko ;

Makarova, Nataliya ;

Ojeda, Francisco ;

Wild, Philipp ;

Lackner, Karl J. ;

Jorgensen, Torben ;

Thorand, Barbara ;

Peters, Annette ;

Nauck, Matthias ;

Petersmann, Astrid ;

Vartiainen, Erkki ;

Veronesi, Giovanni ;

Brambilla, Paolo ;

Costanzo, Simona ;

Iacoviello, Licia ;

Linden, Gerard ;

Yarnell, John ;

Patterson, Christopher C. ;

Everett, Brendan M. ;

Ridker, Paul M. ;

Kontto, Jukka ;

Schnabel, Renate B. ;

Koenig, Wolfgang ;

Kee, Frank ;

Zeller, Tanja ;

Kuulasmaa, Kari .

EUROPEAN HEART JOURNAL, 2016, 37 (30) :2428-+

[7] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[8] Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial [J].

Cardinale, Daniela ;

Ciceri, Fabio ;

Latini, Roberto ;

Franzosi, Maria Grazia ;

Sandri, Maria Teresa ;

Civelli, Maurizio ;

Cucchi, GianFranco ;

Menatti, Elisabetta ;

Mangiavacchi, Maurizio ;

Cavina, Raffaele ;

Barbieri, Enrico ;

Gori, Stefania ;

Colombo, Alessandro ;

Curigliano, Giuseppe ;

Salvatici, Michela ;

Rizzo, Antonio ;

Ghisoni, Francesco ;

Bianchi, Alessandra ;

Falci, Cristina ;

Aquilina, Michele ;

Rocca, Andrea ;

Monopoli, Anna ;

Milandri, Carlo ;

Rossetti, Giuseppe ;

Bregni, Marco ;

Sicuro, Marco ;

Malossi, Alessandra ;

Nassiacos, Daniele ;

Verusio, Claudio ;

Giordano, Monica ;

Staszewsky, Lidia ;

Barlera, Simona ;

Nicolis, Enrico B. ;

Magnoli, Michela ;

Masson, Serge ;

Cipolla, Carlo M. .

EUROPEAN JOURNAL OF CANCER, 2018, 94 :126-137

[9] COVID-19 and Cardiovascular Disease From Bench to Bedside [J].

Chung, Mina K. ;

Zidar, David A. ;

Bristow, Michael R. ;

Cameron, Scott J. ;

Chan, Timothy ;

Harding, Clifford V., III ;

Kwon, Deborah H. ;

Singh, Tamanna ;

Tilton, John C. ;

Tsai, Emily J. ;

Tucker, Nathan R. ;

Barnard, John ;

Loscalzo, Joseph .

CIRCULATION RESEARCH, 2021, 128 (08) :1214-1236

[10] Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers [J].

Clerico, Aldo ;

Zaninotto, Martina ;

Passino, Claudio ;

Aspromonte, Nadia ;

Piepoli, Massimo Francesco ;

Migliardi, Marco ;

Perrone, Marco ;

Fortunato, Antonio ;

Padoan, Andrea ;

Testa, Angelo ;

Dellarole, Franco ;

Trenti, Tommaso ;

Bernardini, Sergio ;

Sciacovelli, Laura ;

Colivicchi, Furio ;

Gabrielli, Domenico ;

Plebani, Mario .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (01) :79-90

← 1 2 3 4 →